Resources for Staying Well
Featured Centers
- Eating Out? Cut Calories, Heartburn
- 5 Good Ways to Save Money on Medicine
- 8 Ways to Treat Your Allergies
HIV and AIDS: Antiretroviral Drugs, Treatments and Medications »
Entry Inhibitors
Entry inhibitors block HIV entry into CD4+ cells.
Fusion inhibitors
The only drug in this class is T-20, which is administered as a twice daily subcutaneous injection. The most common side effect is redness and pain at the site of injection. Rarely, infection can occur at the injection site. There also are reports of generalized allergic reactions.
CCR5 antagonist
Although there were some early concerns of liver inflammation for drugs in this class, MVC appeared to be well tolerated in clinical trials without any specific toxicities attributable to the drug. However, it is a new drug in a new class and the first to actually target the cell. For these reasons, longer follow-up from clinical trials and those followed in the clinic will be very important for assessing the overall safety of the...
Read the HIV and AIDS: Antiretroviral Drugs, Treatments and Medications article »
|
|
Enfuvirtide is an antiviral medication in a group of HIV medicines called fusion inhibitors. Enfuvirtide prevents human immunodeficiency virus (HIV) from entering and taking over the cells in your body.
Enfuvirtide is used to treat HIV, which causes acquired immunodeficiency syndrome (AIDS). Enfuvirtide is not a cure for HIV or AIDS.
Enfuvirtide is usually given after other medications have been tried without successful treatment of HIV.
Enfuvirtide may also be used for other purposes not listed in this medication guide.
Get emergency medical help if you have any of these signs of an allergic reaction: skin rash or hives; fever, chills; nausea, vomiting; difficulty breathing; feeling light-headed or fainting; swelling of your face, lips, tongue, or throat.
Stop using enfuvirtide and call your doctor at once if you have any of these serious side effects:
Less serious side effects may include:
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Before using enfuvirtide, tell your doctor if you are allergic to any drugs, if you take a blood thinner such as Coumadin, or if you have a bleeding or blood clotting disorder, such as hemophilia. You may not be able to use enfuvirtide, or you may need dosage adjustments or special tests during treatment.
Enfuvirtide may increase your risk of developing pneumonia, especially if you have a high viral load, a history of lung disease, or if you smoke. Call your doctor at once if you have symptoms of pneumonia, such as cough, fever, rapid breathing, or shortness of breath.
Do not use enfuvirtide as your only HIV medication. HIV/AIDS is usually treated with a combination of different drugs. Your disease may become resistant to enfuvirtide if you do not use it in combination with other HIV medicines your doctor has prescribed.
To best treat your condition, use all of your medications as directed by your doctor. Do not change your doses or medication schedule without advice from your doctor. Every person with HIV or AIDS should remain under the care of a doctor.
To be sure this medication is helping your condition, your blood will need to be tested on a regular basis. Do not miss any scheduled visits to your doctor.
Stop using enfuvirtide and call your doctor at once if you have serious side effects such as a signs of a new infection, such as fever or chills, cough, or flu symptoms; or severe pain, irritation, or skin changes where you injected the medicine.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.